The Company

Alteco Medical AB is a Swedish company in the biotechnology field.

The company was established in March 2002, in Lund, by a management team with over 30 years of experience each in the biotechnology field.

Alteco Medical AB has developed a unique extracorporeal product - the Alteco® LPS Adsorber for use within the sepsis area. The product is based on new technology which is patented. The adsorber has a high affinity for LPS (Lipopolysaccharide i.e. endotoxin), one of the most potent mediators in gram negative sepsis. The efficacy is confirmed by clinical data from various patient categories. The Alteco® LPS Adsorber reduces endotoxin (LPS) levels in whole blood and positive indications on sepsis markers have been documented. No side effects have been reported.

The Board of Director's of Alteco Medical AB has a vast global network and a great understanding of building and growing international companies.

Board of Directors

Chairman:
Anders Althin, CEO

Members:
Christer Nerme, Senior Vice President
Olof Stocksén
Sigrun Axelsson
Lars Willy Andersen

Alteco Medical AB

President:
Jonas Jönmark

Medical Advisory Board

Chairman:
Lars I Eriksson, MD, PhD
Professor
Dept. of Anesthesiology, Surgical Services and Intensive Care
Karolinska University Hospital, Stockholm, Sweden

Members:
Sten Blomquist, MD, PhD
Associate Professor
Dept. of Cardiothoracic Surgery, Anesthesia and Intensive Care
Skane University Hospital, Lund, Sweden

Lars W. Andersen, MD, DMSc
Associate Professor
Dept. Cardio-Thoracic Anesthesiology and Intensive Care
Heart Center
University of Copenhagen
Rigshospitalet, Denmark

Secretary:
Liselotte Nilsson, Scientific & Product Manager